NCT06372912

Brief Summary

This study examined immediate postoperative complications in patients undergoing various bariatric surgeries, aiming to evaluate the safety and efficacy of these interventions. Conducted at specialized high-volume bariatric surgery centers in Tijuana, Mexico. Predominantly female patients with severe obesity underwent procedures like sleeve gastrectomy and Roux-en-Y gastric bypass. Immediate complications were rare, occurring in only 0.38% of patients, with bleeding being the most common issue. Surgical reintervention within 48 hours was required in 0.33% of cases. The study's low complication rate suggests that surgeon expertise is crucial in minimizing risks and improving postoperative outcomes in bariatric surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2024

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 18, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 18, 2024

Status Verified

April 1, 2024

Enrollment Period

9 months

First QC Date

April 15, 2024

Last Update Submit

April 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of Postoperative Complications

    Within 30 days following surgery, the incidence of anastomotic leaks and surgical site bleeding is the main safety consequence. This outcome measure is essential for proving the safety and enhanced recovery profile, since the technique emphasizes rigorous hemostasis and anastomotic integrity-achieved through reinforced suturing and patency verification using methylene blue tests.

    30 days

Secondary Outcomes (1)

  • Long-term Weight Loss Efficacy

    12 months

Study Arms (1)

Patients undergoing bariatric surgery

Procedure: Sleeve gastrectomy, Roux-en-Y gastric bypass, mini-gastric bypass, SADIS, intragastric balloon insertion, and gastric band placement are bariatric surgeries.

Interventions

Sleeve gastrectomy: reduces stomach size. Roux-en-Y gastric bypass: limits calorie absorption. Mini gastric bypass: achieves weight loss with fewer incisions. SADIS: combines sleeve gastrectomy with small bowel bypass. Intragastric balloon: reduces stomach volume. Gastric banding: restricts food intake.

Patients undergoing bariatric surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study included patients aged 18 and above with varying degrees of overweight or obesity who underwent bariatric surgery at specialized centers in Tijuana, Mexico. The surgeries examined were sleeve gastrectomy, Roux-en-Y gastric bypass, mini-gastric bypass, SADIS, intragastric balloon insertion, and gastric band placement. These procedures were performed by five bariatric surgery specialists with assistance from ten certified subspecialists. Patients with incomplete medical records were excluded. Immediate postoperative complications were defined as events requiring additional medical or surgical interventions beyond routine care.

You may qualify if:

  • Patients aged 18 years and above
  • Varying degrees of overweight or obesity who underwent surgery at the participating hospitals

You may not qualify if:

  • incomplete or insufficient information in their medical records

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elias Ortiz & Company Mexico Weight Loss Specialists. Ernesto Sarmiento 2308, Tijuana 22046, Baja California, Mexico.

Tijuana, Estado de Baja California, 22046, Mexico

RECRUITING

MeSH Terms

Conditions

Postoperative Complications

Interventions

Gastric Bypass

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Bariatric SurgeryBariatricsObesity ManagementTherapeuticsGastroenterostomyAnastomosis, SurgicalSurgical Procedures, OperativeDigestive System Surgical Procedures

Study Officials

  • Jesús E Ortiz Gómez, MD, PhD

    Elias Ortiz & Company Mexico Weight Loss Specialists. Ernesto Sarmiento 2308, Tijuana 22046, Baja California, Mexico.

    STUDY DIRECTOR
  • Almino Cardoso Ramos, MD, PhD

    Elias Ortiz & Company Mexico Weight Loss Specialists. Ernesto Sarmiento 2308, Tijuana 22046, Baja California, Mexico.

    STUDY CHAIR
  • Jaime Ponce de León Palomares, MD, PhD

    Obesity Goodbye Center, Tijuana 2050, Baja California, Mexico.

    STUDY CHAIR
  • José S Verboonen Sotelo, MD, PhD

    Obesity Goodbye Center, Tijuana 2050, Baja California, Mexico

    STUDY CHAIR
  • Jeffry Romero Manzano, MD, PhD

    Obesity Goodbye Center, Tijuana 2050, Baja California, Mexico.

    STUDY CHAIR
  • Isaac Esparza Estrada, MD, PhD

    Obesity Goodbye Center, Tijuana 2050, Baja California, Mexico

    STUDY CHAIR
  • Alejandro González Ojeda, MD, PhD

    Professor at the Faculty of Medicine of the Universidad de Colima. Colima, Mexico

    STUDY CHAIR
  • Christian Rodríguez López, MD, PhD

    Body Art Surgical, Edificio Corporativo Central, Diego Rivera 2311, Zona Urbana Rio Tijuana, 22010 Tijuana, Baja California, Mexico.

    STUDY CHAIR
  • Clotilde Fuentes-Orozco, MD, PhD

    Senior Researcher B, Biomedical Research. Unidad de Investigación Biomédica 02, Unidad Médica de Alta Especialidad, Hospital de Especialidades del Centro Médico Nacional de Occidente del Instituto Mexicano del Seguro Social. Guadalajara, Jalisco. México

    STUDY CHAIR
  • Sergio J Vázquez-Sánchez, MD

    Unidad de Investigación Biomédica 02, Unidad Médica de Alta Especialidad, Hospital de Especialidades del Centro Médico Nacional de Occidente del Instituto Mexicano del Seguro Social

    STUDY CHAIR
  • Hector J Pérez Corzo, MD, PhD

    Renew Bariatrics, Bariatric Surgery Department, Tijuana, Baja California, Mexico

    STUDY CHAIR
  • José O Orozco Álvarez Malo, MD, PhD

    Colegio de Cirujanos Bariatras y Enfermedades Metabólicas del Estado de Baja California. Tijuana 2050, Baja California, Mexico.

    STUDY CHAIR
  • Jhonattan A Barriga Fong, MD, PhD

    Colegio de Cirujanos Bariatras y Enfermedades Metabólicas del Estado de Baja California. Tijuana 2050, Baja California, Mexico

    STUDY CHAIR

Central Study Contacts

José A Guzmán Barba, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 15, 2024

First Posted

April 18, 2024

Study Start

April 1, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 18, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations